CONTACT: Tammi Jacobs
Phone: 480.477.0100

AniCell Biotech launches the EquusCell product line of regenerative therapies for horses that requires no harvesting of bone marrow or fat stem cells.

CHANDLER, AZ, October 5, 2015 – AniCell Biotech launched the EquusCell Brand of regenerative products used for treating tendon and ligament damage as well as treating hard-to-heal superficial and ocular wounds. This product line does not require invasive harvesting or culturing of bone marrow or adipose tissue stem cells to treat injuries in horses. It uses mesenchymal stem cell components from amniotic material collected non-invasively during the parturition of healthy foals to produce these all-natural, minimally manipulated regenerative products.

Dr. Lauren Schnabel DACVS, PhD, DACVSMR, veterinary surgeon and internationally recognized research scientist of stem cell therapies in horses at North Carolina State University said, “I have been extremely impressed with the StemWrap and AlloMatrix products for the treatment of complicated wounds, including those over joints. These products accelerate healing and promote the formation of healthy granulation tissue. They are also well packaged and easy to use.”

“This was my first time using this product, and I was very impressed with the results. The EquusCell products were used to treat a severe, potentially career-ending hock laceration on a yearling filly, and she is healing remarkably well,” claimed Dr. Vanessa Brady of The Equine Center in San Luis Obispo.

Dr. Mike Cissell DACVS-LA, an equine surgeon at Prescott Animal Hospital & Equine Cen